Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
01/13/2006 | CA2566310A1 Scored pharmaceutical tablets comprising a plurality of segments |
01/12/2006 | WO2006005050A2 Load floor latch |
01/12/2006 | WO2006004941A2 Biomaterial |
01/12/2006 | WO2006004940A2 Spinal disc nucleus pulposus implant |
01/12/2006 | WO2006004588A2 Immunodynamic complexes and methods for using and preparing such complexes |
01/12/2006 | WO2006004418A2 Encapsulated tobacco smoke |
01/12/2006 | WO2006004167A1 Sustained-release composition, process for producing the same and use of the same |
01/12/2006 | WO2006003659A2 Delivery system for transdermal immunization |
01/12/2006 | WO2006003645A2 Revolving apparatus for agriculture products cultivation beds |
01/12/2006 | WO2006003581A1 System for manufacturing micro-spheres |
01/12/2006 | WO2006003519A2 Use of emulsions for intra: and periocular injection |
01/12/2006 | WO2006003504A1 Preparation of pharmaceutical compositions containing nanoparticles |
01/12/2006 | WO2006003481A2 Oleaginous pharmaceutical and cosmetic foam |
01/12/2006 | WO2006003474A1 Formation of sugar coatings |
01/12/2006 | WO2006003383A1 Ophthalmic eye preparation |
01/12/2006 | WO2006003152A1 GRANULES COMPRISING A ß-LACTAM ANTIBIOTIC |
01/12/2006 | WO2006003043A1 Oral antimicrobial pharmceutical compositions |
01/12/2006 | WO2006002937A1 Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose |
01/12/2006 | WO2006002886A1 Oral dosage form safeguarded against abuse containing (1r, 2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
01/12/2006 | WO2006002883A1 Method for producing a solid dosage form, which is safeguarded against abuse, while using a planetary gear extruder |
01/12/2006 | WO2006002836A1 Effervescent compositions of sleeping drugs |
01/12/2006 | WO2006002808A2 Rapidly dispersible, fine-grained, separation-resistant pulverulent film coating agent, based on polyvinyl alcohol-polyether graft copolymers and characterised by a particular physical stability and a low degree of roughness |
01/12/2006 | WO2006002769A2 Hollow fibre and the use thereof |
01/12/2006 | WO2006002642A2 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
01/12/2006 | WO2005116130B1 A fast dissolving dried hyaluronic acid product |
01/12/2006 | WO2005107706A3 Biodegradable intravitreal tyrosine kinase inhibitors implants |
01/12/2006 | WO2005097071A3 Manufacture of strong, lightweight carrier granules |
01/12/2006 | WO2005079853A3 Soft gelatin capsule comprising omega-3 polyunsaturated fatty acid |
01/12/2006 | WO2005065319A3 Generally linear effervescent oral fentanyl dosage form and methods of administering |
01/12/2006 | WO2005058362A3 Method for opening tight junctions comprising the use of jam-1, claudin-4 and occludin protein antagonists as well as sirna molecules |
01/12/2006 | WO2005044222A3 Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same |
01/12/2006 | WO2005037949A3 Aerosol formulations of butalbital, lorazepam, ipratropium, baclofen, morphine and scopolamine |
01/12/2006 | WO2005025551A3 Pharmaceutical products comprising bisphosphonates |
01/12/2006 | WO2005011575A3 Stabilization and ionic triggering of nitric oxide release |
01/12/2006 | WO2004080401A3 Oral insulin therapies and protocol |
01/12/2006 | WO2004062712A3 Implantable interface system |
01/12/2006 | WO2003084470A3 Compositions and methods for targeted biological delivery of molecular carriers |
01/12/2006 | US20060009838 Expandable medical device for delivery of beneficial agent |
01/12/2006 | US20060009651 Benzophenones as inhibitors of reverse transcriptase |
01/12/2006 | US20060009505 Anti-cancer composition comprising DMXAA or related compound |
01/12/2006 | US20060009504 Pharmaceutical compositions |
01/12/2006 | US20060009503 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
01/12/2006 | US20060009447 Pharmaceutical compositions comprising midazolam in a high concentration |
01/12/2006 | US20060009437 A medicament containing formoterol or formoterol fumarate and/or mometasone furoate, for simultaneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease; inhalable form in an atomizable composition or in a dry powder |
01/12/2006 | US20060009435 Synthesis and powder preparation of fluticasone propionate |
01/12/2006 | US20060009420 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
01/12/2006 | US20060009397 New use |
01/12/2006 | US20060009387 Apo-2 ligand/trail formulations |
01/12/2006 | US20060009375 Site-specific drug delivery |
01/12/2006 | US20060008910 stable nucleic acid-lipid particles (SNALP) |
01/12/2006 | US20060008909 contains phospholipid and cholesterol, MnSO4 or MgSO4 within, and anticancer agent such as vinca alkaloids; increased retention; leukemia, lymphoma |
01/12/2006 | US20060008892 Methods of and pharmaceutical compositions for improving implantation of embryos |
01/12/2006 | US20060008791 Incorporating saccharide having the structure of cyclo{6)- alpha -D-glucopyranosyl-(1 3)- alpha -D-glucopyransyl-(1 6)- alpha -D-glucopyranosyl-(1 3)- alpha -D-glucopyranosyl-(1}, into, with, or in a food product, cosmetic, pharmaceutical, or industrial chemical containing water |
01/12/2006 | US20060008533 Adsorbates containing active substances |
01/12/2006 | US20060008532 Complexes of protein crystals and ionic polymers |
01/12/2006 | US20060008531 Method for producing solid-lipid composite drug particles |
01/12/2006 | US20060008530 Tissue matrix system |
01/12/2006 | US20060008529 Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers |
01/12/2006 | US20060008527 Controlled phase composition technology as an improved process for protection of drugs |
01/12/2006 | US20060008526 Controlled release metformin compositions |
01/12/2006 | US20060008525 Controlled release metformin compositions |
01/12/2006 | US20060008524 Controlled release metformin compositions |
01/12/2006 | US20060008523 Controlled release metformin compositions |
01/12/2006 | US20060008522 Pharmaceutical excipient having improved compressibility |
01/12/2006 | US20060008521 Tablet excipient |
01/12/2006 | US20060008520 Delayed release formulations of 6-mercaptopurine |
01/12/2006 | US20060008519 Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
01/12/2006 | US20060008518 Useful for more effective resolution of the mechanism of sphingomyelinase |
01/12/2006 | US20060008517 Treatment of age-related memory impairment |
01/12/2006 | US20060008516 Gilsonite derived pharmaceutical delivery compositions and methods: cosmetic applications |
01/12/2006 | US20060008515 Anti-microbial chitosan composition for textile products |
01/12/2006 | US20060008514 Wipe and methods for improving skin health |
01/12/2006 | US20060008513 Paper substrates and articles containing antimicrobial components as well as methods of making and using the same |
01/12/2006 | US20060008508 Dry powder; administering htrough feeding tube |
01/12/2006 | US20060008506 Method for preparing therapeutic ophthalmic articles using compressed fluids |
01/12/2006 | US20060008501 prosthesis, shunt, catheter or local drug delivery device with coating of a biocompatible chemically hardened oil or fat containing a therapeutic agent; e.g. partially hydrogenated oil or fat |
01/12/2006 | US20060008498 Nano-particle production |
01/12/2006 | US20060008483 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles |
01/12/2006 | US20060008481 Topically applying bactericide gentian violet (methylrosaniline) and a suppository base; soothing and healing effect |
01/12/2006 | US20060008480 comprising vinorelbine bitartrate in an oil-in-water emulsion having an oil phase and an aqueous phase; oil phase comprises a triglyceride oil having medium chain fatty acids, soy lecithin, and oleic acid; aqueous phase comprises water, sucrose, and disodium edetate (EDTA) dihydrate |
01/12/2006 | US20060008461 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
01/12/2006 | US20060008447 Comprises purified mannitol which reduces formation of interferon-beta adducts |
01/12/2006 | US20060008443 Ophthalmic compositions for lubricating eyes and methods for making and using same |
01/12/2006 | US20060008440 Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins |
01/12/2006 | US20060008427 Sunscreen compositions with SPF enhancer |
01/12/2006 | US20060008425 Antiplaque oral composition containing enzymes and cyclodextrins |
01/12/2006 | US20060008421 Pharmaceutical combination |
01/12/2006 | US20060008420 Nasal spray formulation and method |
01/12/2006 | US20060006560 Display capsules and a method of manufacturing thereof |
01/12/2006 | US20060005832 Inhaler using pods |
01/12/2006 | DE4216644B4 Liposomen enthaltende Arzneimittel Liposomes containing drugs |
01/12/2006 | DE19925211B4 Kit zur Herstellung einer Formulierung von Paclitaxel Kit for preparing a formulation of paclitaxel |
01/12/2006 | DE102004031955A1 Wundauflage Wound dressing |
01/12/2006 | DE102004031298A1 Wässrige Dispersionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver enthaltend mindestens ein Polyethergruppen enthaltendes Polymer als Schutzkolloid Aqueous dispersions of poorly water-soluble or water-insoluble drugs and derived dry powder containing at least one polyether-containing polymer as a protective colloid |
01/12/2006 | DE102004031014A1 Vorrichtung zur gezielten Freistzung von Stoffen in einem Hohlraum A device for targeted Freistzung of substances in a cavity |
01/12/2006 | DE102004030880A1 Methode zur Behandlung von Diabetes Method for the treatment of diabetes |
01/12/2006 | DE102004030504A1 Multi-particulate formulation, useful to generate a pH-value dependent active substance release in treating inflammatory intestinal diseases, comprises encapsulated medicine and/or natural substances |
01/12/2006 | DE102004030044A1 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels Triterpenhaltiger oleogel-forming agent, triterpenhaltiges oleogel and method for producing a triterpenhaltigen oleogel |
01/12/2006 | DE102004028940A1 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält Orally disintegrating pharmaceutical composition containing risperidone |
01/12/2006 | DE10102817B4 Vorrichtung und Verfahren zur Hitzepulsgestützten transdermalen Applikation von Wirkstoffen Apparatus and method for heat pulse-assisted transdermal application of active substances |